As the world continues to adapt to the impact of the pandemic, a legacy has seen the evolvement of varying approaches to how clinical trials are designed and deployed. There has been a rapid rise in decentralised clinical trials (DCT) which brings benefits and poses potential challenges in equal measure. Lee Stopher at Peli BioThermal, analysis the rapid rise of decentralised clinical trials.